FAQ/Help |
Calendar |
Search |
Today's Posts |
|
ALS News & Research For postings of news or research links and articles related to ALS |
Reply |
|
Thread Tools | Display Modes |
03-20-2017, 11:02 AM | #1 | |||
|
||||
Grand Magnate
|
AB Science announces positive top-line results of final analysis from study AB10015 of masitinib in amyotrophic lateral sclerosis (ALS)
AB Science announces positive top-line results of final analysis from study AB1 15 of masitinib in amyotrophic lateral sclerosis (ALS) Paris Stock Exchange:AB |
|||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
NeuroDerm Announces Positive Topline Results of Phase II Trials | Parkinson's Disease | |||
Civitas Therapeutics Announces Positive Phase 2b Results for CVT-301, Inhaled Levodop | Parkinson's Disease | |||
Hisamitsu announces positive Phase II results for Parkinson’s disease drug | Parkinson's Disease | |||
NeuroDerm Announces Positive Results of a Phase II Study of ND0611 Dermal Patch in Pa | Parkinson's Disease | |||
Ceregene announces positive phase 1 results ... | Parkinson's Disease |